KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Enterprise Value Growth (1y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -82.06%
Dec 31, 2025 5.46%
Sep 30, 2025 22.33%
Jun 30, 2025 51.03%
Mar 31, 2025 71.52%
Dec 31, 2024 56.84%
Sep 30, 2024 45.33%
Jun 30, 2024 -50.15%
Mar 31, 2024 -169.37%
Dec 31, 2023 -38.96%
Sep 30, 2023 -11.89%
Jun 30, 2023 12.01%
Mar 31, 2023 11.25%
Dec 31, 2022 6.18%
Sep 30, 2022 3.08%
Jun 30, 2022 -15.76%
Mar 31, 2022 22.69%
Dec 31, 2021 -15.89%
Sep 30, 2021 -54.10%
Jun 30, 2021 -42.54%
Mar 31, 2021 76.29%
Dec 31, 2020 78.81%
Sep 30, 2020 25.52%
Jun 30, 2020 -11.08%
Mar 31, 2020 -686.95%
Dec 31, 2019 -395.27%
Sep 30, 2019 -21.21%
Jun 30, 2019 -44.70%
Mar 31, 2019 44.82%
Dec 31, 2018 17.65%
Sep 30, 2018 8.05%
Jun 30, 2018 48.05%
Mar 31, 2018 -51.63%
Dec 31, 2017 -52.41%
Sep 30, 2017 -20.18%
Jun 30, 2017 9.96%
Mar 31, 2017 27.35%
Dec 31, 2016 23.60%
Sep 30, 2016 14.04%
Jun 30, 2016 3.35%
Mar 31, 2016 -8.53%
Dec 31, 2015 -0.39%
Sep 30, 2015 -19.68%
Jun 30, 2015 19.20%
Mar 31, 2015 12.92%
Dec 31, 2014 15.37%
Sep 30, 2014 19.47%
Jun 30, 2014 -17.04%
Mar 31, 2014 -21.67%
Dec 31, 2013 -24.06%
Sep 30, 2013 -247.56%
Jun 30, 2013 -11,729.73%
Mar 31, 2013 -18,141.46%